HER3 expression or overexpression has been described in multiple types of tumors, including breast [31], ovarian [32, 33], lung [11], colon [34], pancreatic [10], melanoma [35], gastric [9, 36], head and neck [37] and prostate cancers [12]. This evidence concerns the gene ERBB3 and prostate carcinoma.